Chimamanda Udodi ’28
For over a century, modern medicine has depended heavily on pharmaceuticals to treat disease. Antibiotics, antidepressants, antihypertensives, and biologic drugs have transformed healthcare and saved millions of lives. While these molecular interventions are undeniably transformative, they often rely on systemic circulation, traveling throughout the entire body to reach a single target. In turn, this lack of precision causes unwanted side effects or failure to fully resolve a condition (Hendry, 2023). In the last decade, a new idea has been gaining ground — what if some illnesses could be treated not with chemicals, but with precisely targeted electrical signals?
That is the promise of bioelectronic medicine, a growing field that explores how fine-tuning the body’s own electrical language can restore health. Many experts believe it may become one of the most exciting and transformative advancements in healthcare.
The concept behind bioelectronic medicine is surprisingly intuitive. The nervous system governs nearly every process in the body by sending rapid electrical signals along neural circuits. When those signals are disrupted — by injury, disease, or chronic inflammation — normal function breaks down. Traditional pharmaceuticals attempt to correct this disruption indirectly by altering the body’s chemical environment. They do so by adding molecules that amplify, dampen, or mimic biological signals to compensate for faulty neural communication. Rather than introducing a drug to force a chemical change, bioelectronic treatments aim to recalibrate those electrical messages at their source.
Electrical communication is the body’s first language. Every heartbeat, every muscle movement, every immune response depends on neurons firing tiny electrical impulses. When these neural signals are disrupted, the coordinated functioning of physiological systems deteriorates, giving rise to disease. Bioelectronic medicine intervenes at the level of specific neural circuits, delivering targeted electrical stimulation to recalibrate signaling patterns and restore functional balance.
This concept of electrical healing is not entirely a product of the twenty-first century. Pacemakers have long used electrical stimulation to maintain a stable heart rhythm. Deep brain stimulation has dramatically improved quality of life for people with Parkinson’s disease by interrupting abnormal neural patterns (Okun, 2012). Today, advances in neuroscience, engineering, and immunology reveal that similar approaches could affect far more than motor function— emerging research suggests electrical stimulation may influence inflammation, metabolism, mental health, and even immune function (Olofsson & Tracey, 2017). These findings are opening the door to therapies that are more precise, more adaptable, and possibly safer than many medications currently in use.
These technologies are becoming more accessible and patient-friendly due to recent advancements like wearable neurostimulation patches and bioresorbable nerve interfaces–temporary electronic implants designed to safely dissolve in the body after delivering targeted stimulation (Oh et al., 2024). This change reflects a more comprehensive vision of medicine in which human biology and digital technology are seamlessly combined to deliver ongoing, individualized care.
One of the most significant breakthroughs in this field involves the vagus nerve, which serves as a vital communication superhighway between the brain and the internal organs. Researchers have found that by activating particular fibers in this nerve, they can actually change immune cell activity to reduce systemic inflammation. This discovery has contributed to the development of bioelectronic medicine as a distinct field of study (Pavlov, Chavan, & Tracey, 2020). Clinical trials investigating vagus nerve stimulation for a variety of conditions, such as major depression, Crohn’s disease, and rheumatoid arthritis, have increased dramatically as a result of this discovery. Patients who were previously unresponsive to conventional medications have frequently found relief from these electrical interventions (Koopman et al., 2016), without the systemic toxicity linked to long-term pharmaceutical use (Pavlov & Tracey, 2019).
Beyond its effectiveness, bioelectronic therapy provides a degree of accuracy that is difficult for conventional medicine to match. While a pill interacts with tissues far beyond its intended target, electrical stimulation can be delivered to highly specific neural subregions to minimize off-target effects. We are currently moving toward the reality of “electrical prescriptions” that are uniquely tailored to a patient’s individual physiological patterns.
In order to combat symptoms before they worsen, engineers are now creating closed-loop systems—devices that continuously sense a patient’s biological signals in real time and automatically adjust stimulation in response (Leng & Sun, 2025). This level of precision is not possible with a static dose of medication. Such closed-loop systems could manage chronic pain and metabolic disorders by intervening precisely when dysfunctional signaling arises. Because these devices are designed for continuous use, either as discreet wearables or minimally invasive implants, they can provide adaptive treatment over time rather than delivering constant stimulation. Additionally, the field is rapidly shifting away from the need for invasive surgeries.
Even though bioelectronic medicine holds great promise, there are important ethical and practical concerns as it moves from the lab to widespread clinical use. Because these devices can be expensive to develop and implement, there is a good chance that access will be uneven, which could exacerbate already-existing health disparities. Furthermore, sensitive physiological data recorded by wearable or implanted devices raises important concerns about patient autonomy, privacy, and long-term data security. As the field advances toward widespread adoption, researchers and regulators must work together to ensure the dependability and safety of these devices over decades (Mariello, 2025).
Given the current momentum in this field, bioelectronic medicine is likely to become a defining feature of healthcare in the twenty-first century. While the pharmaceutical industry dominated the previous century, the next one might be characterized by treatments that restore the body’s natural electrical language. This movement is a fundamental rethinking of medical care, not just a new set of tools. With a rapidly expanding body of evidence, the notion that electricity can heal has evolved to a scientific reality. As these technologies develop further, they will probably alter not only how we treat illness but also how we view the interaction between technology and biology.
Chimamanda Udodi is a staff writer at The Princeton Medical Review. She can be reached at cu8222@princeton.edu.
References
Hendry, W. (2023). Examination of pharmaceutical complications: The impact of drug side effects. International Journal of Pharmacy, 13(5), 69. https://www.pharmascholars.com/articles/examination-of-pharmaceutical-complications-the-impact-of-drug-side-effects-102641.html
Koopman, F. A., Chavan, S. S., Miljko, S., Grazio, S., Sokolovic, S., Schuurman, P. R., Mehta, A. D., Levine, Y. A., Faltys, M., Zitnik, R., Tracey, K. J., & Tak, P. P. (2016). Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proceedings of the National Academy of Sciences, 113(29), 8284–8289. https://doi.org/10.1073/pnas.1605635113
Mariello, M. (2025). Reliability and stability of bioelectronic medicine: A critical and pedagogical perspective. Bioelectronic Medicine, 11(16). https://doi.org/10.1186/s42234-025-00179-4
Oh, S., Jekal, J., Liu, J., Kim, J., Park, J. U., Lee, T., & Jang, K. I. (2024). Bioelectronic implantable devices for physiological signal recording and closed-loop neuromodulation. Advanced Functional Materials, 34(41), 2403562. https://doi.org/10.1002/adfm.202403562
Okun, M. S. (2012). Deep-brain stimulation for Parkinson’s disease. The New England Journal of Medicine, 367(16), 1529–1538. https://doi.org/10.1056/NEJMct1208070
Olofsson, P. S., & Tracey, K. J. (2017). Bioelectronic medicine: Technology targeting molecular mechanisms for therapy. Journal of Internal Medicine, 282(1), 3–4. https://doi.org/10.1111/joim.12624
Pavlov, V. A., Chavan, S. S., & Tracey, K. J. (2020). Bioelectronic medicine: From preclinical studies on the inflammatory reflex to new approaches in disease diagnosis and treatment. Cold Spring Harbor Perspectives in Medicine, 10(3), a034140. https://doi.org/10.1101/cshperspect.a034140
Pavlov, V. A., & Tracey, K. J. (2019). Bioelectronic medicine: Updates, challenges and paths forward. Bioelectronic Medicine, 5(1), 1–13. https://doi.org/10.1186/s42234-019-0018-y
Leave a Reply